Business
from24/7 Wall St.
14 hours agoAfter Microsoft's Q1 Slide, Are the Bulls Still On Board?
Microsoft's stock is significantly undervalued compared to analyst price targets, despite strong revenue growth and consistent earnings performance.
#stock-analysis
#stock-analysis
[ follow ]
#investment #earnings-report #market-trends #financial-performance #nvidia #dividend-stocks #electric-vehicles #ai
Business
from24/7 Wall St.
3 weeks agoGoldman Sachs Raises Price Targets on 3 Tech Giants by 10% and More
Goldman Sachs raised price targets by 10% or more on three Buy-rated companies, signaling analyst optimism about growth prospects over the next 6-12 months, with Analog Devices highlighted as a semiconductor company offering solid entry points for growth investors.
Venture
from24/7 Wall St.
3 weeks agoRBC Sets Kinross Gold Price Target at $45 - Here's What Has to Go Right for KGC to Get There
Kinross Gold has surged 188% over the past year, with RBC Capital upgrading the stock to Outperform and raising its price target to $45, citing strong free cash flow generation, gold price leverage, and shareholder-friendly capital returns.
from24/7 Wall St.
3 weeks agoWhen Fear Spikes, These 5 Quiet, Overlooked Stocks Keep Delivering
When fear spikes, most investors flee to gold or Treasuries. But five quietly resilient stocks have been doing the work all along, and most investors aren't paying attention. The ranking below weighs dividend stability, earnings consistency, balance sheet strength, and cash flow predictability in a turbulent environment.
Business intelligence
Healthcare
from24/7 Wall St.
4 weeks agoThis 1 Dividend Stock Outperformed the Nasdaq Last Year and Can Do It Again
American Healthcare REIT (AHR) offers exceptional growth potential through healthcare real estate investments, combining stable healthcare demand with significant capital appreciation despite low dividend yields.
Business
from24/7 Wall St.
4 weeks agoThese 3 Stocks Just Bounced From Lows - What Wall Street Thinks Comes Next
Trade Desk shows cautious analyst support with limited upside, Moderna trades significantly above consensus targets with skeptical ratings, and Strategy exhibits strong bullish conviction despite volatility.
Business intelligence
from24/7 Wall St.
4 weeks ago2 Top Growth Stocks to Buy, And 1 to Sell Right Away
Three lesser-known stocks warrant portfolio consideration: HubSpot presents a buying opportunity with strong earnings growth and reasonable valuation, Sanmina offers exposure to critical infrastructure, while a third company should be avoided to free capital for better opportunities.
Venture
from24/7 Wall St.
1 month agoJPMorgan's Top Short Ideas, 5 Weeks Later: Were They Right?
JPMorgan's January 2026 short recommendations on Fortinet, Joby Aviation, and Transocean show mixed results five weeks later, with Joby declining 26.1%, Fortinet relatively flat, and Transocean rising significantly.
from24/7 Wall St.
1 month ago5 High Yielding Stocks that Raised their Dividends by 50% over the last five years
Aggressively invest in high-yielding stocks and reinvest the dividends continuously until you consider retirement. After all, each reinvested dividend payout buys you more income-producing shares without any out-of-pocket expenses. Better, by doing so, you're compounding the earnings and expediting the growth of your portfolio.
Retirement
fromTipRanks Financial
6 months agoQualcomm (QCOM) Chooses Adobe's AI Platform to Improve Its Marketing - TipRanks.com
Tech giants Adobe (ADBE) and Qualcomm (QCOM) are expanding their relationship with the use of Adobe GenStudio, which is a generative AI platform that makes content creation faster and more efficient. Indeed, Qualcomm plans to use the system to improve how its marketing teams develop and deliver personalized campaigns. More specifically, GenStudio will help automate work such as resizing, translating, and creating variations of marketing materials, while also linking together workflows across teams.
Marketing tech
fromTipRanks Financial
6 months agoRepublic Technologies Enhances Governance and Launches Marketing Campaign - TipRanks.com
Spark's Take on TSE:DOCT StockAccording to Spark, TipRanks' AI Analyst, TSE:DOCT is a Underperform. The overall stock score for Beyond Medical Technologies Inc is significantly impacted by its critical financial health, characterized by zero revenue and negative profitability. While technical indicators show short-term positive momentum, the overbought conditions and poor valuation metrics suggest caution. Immediate strategic changes are necessary for financial recovery and sustainable growth.
Business
fromTipRanks Financial
8 months agoDistrict Copper Corp Partners with Capitaliz On It for Investor Relations Boost - TipRanks.com
District Copper Corp has partnered with Capitaliz On It for a digital marketing campaign to increase investor awareness and attract new investors, enhancing market presence.
Miscellaneous
:max_bytes(150000):strip_icc()/GettyImages-2219098831-be7c1841a0e04883ae42f5666b1a707f.jpg)
[ Load more ]